brewer's yeast

(redirected from Saccharomyces boulardii)
Also found in: Dictionary, Thesaurus, Medical, Wikipedia.

brewer's yeast:

see yeastyeast,
name applied specifically to a certain group of microscopic fungi and to commercial products consisting of masses of dried yeast cells or of yeast mixed with a starchy material and pressed into yeast cakes.
..... Click the link for more information.
.
The Columbia Electronic Encyclopedia™ Copyright © 2013, Columbia University Press. Licensed from Columbia University Press. All rights reserved. www.cc.columbia.edu/cu/cup/
References in periodicals archive ?
Microorganisms applied in probiotic products Yeasts LAB Saccharomyces cerevisiae Enterococcus faecalis Saccharomyces boulardii Enterococcus faecium Lactococcus lactis subsp.
Kolodziej, "Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection," Alimentary Pharmacology & Therapeutics, vol.
Gunay, "Saccharomyces boulardii expresses neuraminidase activity selective for a2,3-linked sialic acid that decreases Helicobacter pylori adhesion to host cells," APMIS, vol.
* Probiotics in yogurt, the fermented milk product kefir, and commercial probiotic products may help standard therapy work better and could lessen treatment side effects (look for Lactobacillus or Saccharomyces boulardii).
Saccharomyces boulardii, a component of several probiotic supplements, was initially classified as a novel species of the genus Saccharomyces.
(28) Various probiotics were used including Lactobacillus species, Streptococcus thermophilus, Bifidobacterium species, and Saccharomyces boulardii for between 4 and 10 days.
ENTEROL is an ethical pharmaceutical specialty composed of lyophilised Saccharomyces boulardii living cells in a concentration of 250 mg per capsule, or per sachet registered in Romania in packs of 10 capsules and sachets under the trademark ENTEROL.
Im and Pothoulakis (2010) report that the yeast Saccharomyces boulardii is highly beneficial to the host because it alters bacterial virulence, releases toxin-breaking enzymes and decreases inflammatory response.
Major finding: The probiotic yeast Saccharomyces boulardii does not appear to have any beneficial effects for patients with Crohn's disease who are in remission.